Cure for deafness: Breakthrough gene drug Otarmeni set to be offered FREE to American children with total hearing loss following FDA approval

A breakthrough gene therapy drug, Otarmeni, has received FDA approval and will be provided free to American children with total hearing loss. This development marks a significant advancement in treating congenital hearing impairment through gene therapy.